Governance / Clinical-grade
Phase 1 / Pilot intake open
Investor Relations

Veterinary intelligence,
governed and investable.

VETA Intelligence is commercialising the NPM Integrator IP as a regulated, evidence-first platform for the global animal health economy. We are raising a Pre-Seed / Seed round to fund clinical validation, platform hardening, and the first three pilot clinics.

StageSeed Round
Raise target$15M – $20M
Runway18 mo post-close
Dilution15–20% target
Executive overview

VETA Pro.

A 90-second walkthrough of the opportunity: the veterinary intelligence engine, clinical governance model, and the three-channel go-to-market. For investor and partner review.

Channel 02 / VETAi

VETAi for Pet Owners.

A product walkthrough of the consumer-facing triage surface: species-aware intake, escalation logic, and the clinic handoff experience. Target: Q1 post-close.

Investor deck

Download the full investor deck.

An 18-slide overview of the thesis, engine, three commercial channels, market, traction, business model, and the ask. Preliminary copy — confidential, for investor review only.

PDF
v1.0 — preliminary
VETA Intelligence — Investor Deck
18 slides · PDF · 412 KB · Confidential
Market & opportunity

A $12B+ animal health data market with no governance layer.

01 / 03
$12.4B
Global veterinary diagnostics data market (2024 est.)

Fragmented across PIMS, lab systems, and consumer apps. No unified evidence standard exists.

02 / 03
47,000+
US veterinary clinics

Majority are independent small-animal practices with limited IT budget and no in-house AI expertise.

03 / 03
0
Governed veterinary LLM platforms at scale

General-purpose models are used ad-hoc. No platform offers deterministic, auditable clinical output.

Traction & milestones

Pilots before press releases. Evidence before promises.

Pilots committed
3 clinics

Letters of intent signed. Protocol design in progress.

Clinical advisory board
Seated

3 DVMs + 1 PhD toxicologist. Biweekly cadence.

IP status
NPM Integrator

Core evidence-routing engine. In-house ownership.

Design partners
2 engaged

Enterprise animal health data buyers. API feedback loop active.

Use of funds

Every dollar is mapped to a gate. No general-purpose budgets.

01
Clinical validation & pilots
35%
3 clinic pilots, IRB-adjacent protocol, evidence corpus build-out
02
Engineering & platform
30%
6-gate pipeline hardening, PIMS integrations, security audit
03
Regulatory & compliance
15%
US veterinary regulatory counsel, Canada fast-follow prep, privacy review
04
Go-to-market
12%
Design partner acquisition, VETAi closed-beta ops, sales tooling
05
Reserve
8%
Unplanned clinical or regulatory milestones
Governance

Safety-first governance is not overhead. It is the moat.

01 / 03
Clinical advisory veto

The clinical board has explicit veto rights over any feature that touches safety-critical output.

02 / 03
Evidence ownership

All training and inference evidence is owned in-house. No third-party model dependency without board approval.

03 / 03
Audit by default

Every inference carries a traceable evidence log. Not a feature — a schema requirement from day one.

Request the full data room.

Detailed financial model, cap table, clinical protocol drafts, and technical architecture documents available under NDA. Select “Investor” on the contact form.